The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has received a renewed five-year $10.8 million Specialized Program of Research Excellence (SPORE) grant from the National Cancer Institute for the Lurie Cancer Center to advance translational research and improve outcomes for patients with brain cancer.
Northwestern Medicine investigators have developed a novel nanoparticle treatment for glioblastoma, according to a study published in Nature Communications.
Northwestern Medicine scientists have identified an enzyme which aids tumors in evading the immune system, findings that could provide future directions for tumor treatment, according to a study published in Nature Communications.
Northwestern University scientists have developed a first-of-its-kind small, flexible, stretchable bandage that accelerates healing by delivering electrotherapy directly to the wound site.
Scientists have developed the first wearable device to track how much people use their voices, alerting them to overuse before fatigue and potential injury set in.
Scientists have developed a wireless, battery-free implant capable of monitoring dopamine signals in the brain in real-time, an advance that could aid in understanding the role neurochemicals play in neurological disorders.
Northwestern investigators have developed a deep learning-based method that can predict cognitive function capacity based on brain shape and structure, detailed in a study published in Scientific Reports.
A new study has identified a drug that inhibits growth of aggressive meningiomas and how to most accurately identify which tumors will respond to the drug.
A team led by Northwestern Medicine investigators has discovered differences in the distribution and interaction of T-cells within different parts of brain tumor and brain metastasis microenvironments.
Scientists have discovered a potential biomarker that could more accurately identify which patients with non-hypermutated cancers will respond to specialized immunotherapy drugs.
